IP Library › Granted Patent US 12,207,951
Granted Patent B2
US 12,207,951 · App. 17/832,405 · Granted Jan 28, 2025

Systems and methods for detection of potential health issues

Inventors: Eric Bergman (Newton, MA); Jonathan Leclerc (Northborough, MA); David Yuds (Hudson, NH); Maria Tamayo-Coffey (Pleasanton, CA); Jessica Steuber (Berlin, MA)
Assignee: Fresenius Medical Care Holdings, Inc.
A61B5/7275A61B5/0205A61B5/746G01G19/50G16H50/30A61B3/12A61B5/021A61B5/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,207,951
App. No.
17/832,405
Granted
Jan 28, 2025
Kind
B2
Abstract

A device for detecting potential health issues includes a retinal scanner configured to capture retinal data of the user, a blood pressure sensor configured to capture blood pressure data of the user, an alert module configured to alert the user of a potential health risk, and at least one processor communicatively coupled to the retinal scanner, the blood pressure sensor, and the alert module.

Claims (61)

1. A device for detecting potential kidney diseases, comprising:

at least one sensor configured to capture sensor data corresponding to a user;

an audible or visual indicator; and

at least one processor communicatively coupled to the at least one sensor and the audible or visual indicator, the at least one processor configured to execute non-transitory computer-executable instructions that, when executed, cause the at least one processor to carry out operations comprising:

causing the at least one sensor to capture sensor data corresponding to the user, the captured sensor data comprising retinal image data of the user;

receiving, at the at least one processor from the at least one sensor, the captured sensor data;

processing, by the at least one processor, the captured sensor data to determine at least one of a cardiac output of the user or a hydration status of the user;

processing, by the at least one processor, the retinal image data to measure at least one of a volume of a retina of the user, a total thickness of the retina of the user, or a central subfield mean retinal thickness;

determining, by the at least one processor based on the processed retinal image data and the at least one of the cardiac output of the user or the hydration status of the user, a risk that the user has at least one kidney disease; and

transmitting, by the at least one processor, a signal representing the risk that the user has at least one kidney disease to the audible or visual indicator for presenting the risk to the user.

2. The device of claim 1 , wherein:

the at least one sensor comprises a weight sensor communicatively coupled to the at least one processor; and

determining a risk that the user has at least one kidney disease is further based on processing, by the at least one processor, the captured sensor data to determine the weight of the user.

3. The device of claim 1 , wherein:

the at least one sensor comprises a urinalysis sensor communicatively coupled to the at least one processor; and

determining a risk that the user has at least one kidney disease is further based on processing, by the at least one processor, the captured sensor data to determine urinalysis data of the user.

4. The device of claim 1 , wherein presenting the risk to the user comprises presenting, by the audible or visual indicator to the user, a recommendation that the user visit a healthcare provider.

5. The device of claim 1 , wherein determining the risk that the user has at least one kidney disease further comprises:

processing the captured sensor data to determine a health risk value; and

comparing the health risk value to a threshold health risk value.

6. The device of claim 5 , wherein determining the health risk value comprises weighting the processed sensor data in accordance with a predetermined weighting scheme.

7. The device of claim 1 , wherein presenting the risk to the user comprises generating a print-out having a summary of a plurality of risk factors.

8. The device of claim 1 , further comprising a user interface configured to capture lifestyle data of the user, wherein the operations further comprise:

receiving, from the user interface, lifestyle data of the user; and

the risk that the user has at least one kidney disease is determined based partly on the received lifestyle data.

9. The device of claim 1 , wherein determining the risk that the user has at least one kidney disease comprises determining a risk that the user has chronic kidney disease.

10. The device of claim 1 , wherein:

processing the retinal image data comprises processing, by the at least one processor, the retinal image data to measure the volume of the retina of the user; and

determining the risk that the user has at least one kidney disease comprises determining, by the at least one processor based on the volume of the retina of the user and the at least one of the cardiac output of the user or the hydration status of the user, the risk that the user has at least one kidney disease.

11. A method, comprising:

causing at least one sensor to capture sensor data corresponding to a user, the captured sensor data comprising retinal image data of the user;

receiving, from the at least one sensor, the captured sensor data;

processing the captured sensor data to determine at least one of a cardiac output of the user or a hydration status of the user;

processing the retinal image data to measure at least one of a volume of a retina of the user, a total thickness of the retina of the user, or a central subfield mean retinal thickness;

determining, based on the processed retinal image data and the at least one of the cardiac output of the user or the hydration status of the user, a risk that the user has at least one kidney disease; and

transmitting a signal representing the risk that the user has at least one kidney disease to an audible or visual indicator for presenting the risk to the user.

12. The method of claim 11 , wherein:

the at least one sensor comprises a weight sensor; and

determining a risk that the user has at least one kidney disease is further based on processing the captured sensor data to determine the weight of the user.

13. The method of claim 11 , wherein:

the at least one sensor comprises a urinalysis sensor; and

determining a risk that the user has at least one kidney disease is further based on processing the captured sensor data to determine urinalysis data of the user.

14. The method of claim 11 , wherein presenting the risk to the user comprises causing the audible or visual indicator to present, to the user, a recommendation that the user visit a healthcare provider.

15. The method of claim 11 , wherein determining the risk that the user has at least one kidney disease further comprises:

processing the captured sensor data to determine a health risk value; and

comparing the health risk value to a threshold health risk value.

16. The method of claim 15 , wherein determining the health risk value comprises weighting the processed sensor data in accordance with a predetermined weighting scheme.

17. The method of claim 11 , further comprising, receiving, from a user interface, lifestyle data of the user, wherein the risk that the user has at least one kidney disease is determined based partly on the received lifestyle data.

18. The method of claim 11 , wherein:

processing the retinal image data comprises processing the retinal image data to measure the volume of the retina of the user; and

determining the risk that the user has at least one kidney disease comprises determining, based on the volume of the retina of the user and the at least one of the cardiac output of the user or the hydration status of the user, the risk that the user has at least one kidney disease.

19. A non-transitory computer-readable storage medium having instructions executable by one or more processors to cause the processors to perform operations comprising:

causing at least one sensor to capture sensor data corresponding to a user, the captured sensor data comprising retinal image data of the user;

receiving, from the at least one sensor, the captured sensor data;

processing the captured sensor data to determine at least one of a cardiac output of the user or a hydration status of the user;

processing the retinal image data to measure at least one of a volume of a retina of the user, a total thickness of the retina of the user, or a central subfield mean retinal thickness;

determining, based on the processed retinal image data and the at least one of the cardiac output of the user or the hydration status of the user, a risk that the user has at least one kidney disease; and

transmitting a signal representing the risk that the user has at least one kidney disease to an audible or visual indicator for presenting the risk to the user.

20. The non-transitory computer-readable storage medium of claim 19 , wherein:

processing the retinal image data comprises processing the retinal image data to measure the volume of the retina of the user; and

determining the risk that the user has at least one kidney disease comprises determining, based on the volume of the retina of the user and the at least one of the cardiac output of the user or the hydration status of the user, the risk that the user has at least one kidney disease.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2022
From: BERGMAN, ERIC; LECLERC, JONATHAN; YUDS, DAVID; TAMAYO-COFFEY, MARIA; STEUBER, JESSICA
To: FRESENIUS MEDICAL CARE HOLDINGS, INC.
Reel/Frame 060919/0759 →
Continuity (2)
Continuation 16534319 · Aug 7, 2019
Related Publication 20220296175A1 · Sep 22, 2022
References Cited (52)
US 9828637B2 · Genovese et al. · 2017 [cited by applicant]
US 10978176B2 · Cha et al. · 2021 [cited by applicant]
US 11350887B2 · Bergman · 2022 [cited by examiner]
US 20050261558A1 · Eaton et al. · 2005 [cited by applicant]
US 20050272101A1 · Devarajan et al. · 2005 [cited by applicant]
US 20080292151A1 · Kurtz et al. · 2008 [cited by applicant]
US 20100190164A1 · Tammen et al. · 2010 [cited by applicant]
US 20110033942A1 · Hess et al. · 2011 [cited by applicant]
US 20110257891A1 · Akonur et al. · 2011 [cited by applicant]
US 20120034240A1 · Kas et al. · 2012 [cited by applicant]
US 20120077690A1 · Singbartl et al. · 2012 [cited by applicant]
US 20130079244A1 · Genovese et al. · 2013 [cited by applicant]
US 20130143806A1 · Nelsestuen · 2013 [cited by applicant]
US 20130323751A1 · Singbartl et al. · 2013 [cited by applicant]
US 20130330829A1 · Demirjian · 2013 [cited by applicant]
US 20140354949A1 · Bakar et al. · 2014 [cited by applicant]
US 20140377777A1 · Anderberg et al. · 2014 [cited by applicant]
US 20150056641A1 · Anderberg et al. · 2015 [cited by applicant]
US 20150241415A1 · Anderberg et al. · 2015 [cited by applicant]
US 20160342764A1 · Hermida Domingez · 2016 [cited by examiner]
US 20160357923A1 · Dong et al. · 2016 [cited by applicant]
US 20170007126A1 · Shahar · 2017 [cited by applicant]
US 20170046487A1 · Tran · 2017 [cited by applicant]
US 20170147770A1 · Xu et al. · 2017 [cited by applicant]
US 20180074054A1 · McPherson et al. · 2018 [cited by applicant]
US 20180095091A1 · Wang · 2018 [cited by applicant]
US 20180105880A1 · Genovese et al. · 2018 [cited by applicant]
US 20180110455A1 · Chang et al. · 2018 [cited by applicant]
US 20180235467A1 · Celenk et al. · 2018 [cited by applicant]
US 20180253840A1 · Tran · 2018 [cited by examiner]
US 20190313903A1 · McKinnon · 2019 [cited by examiner]
US 20200005900A1 · Cha · 2020 [cited by examiner]
US 20210038165A1 · Bergman et al. · 2021 [cited by applicant]
CN 108573753 · 2018 [cited by applicant]
DE 19920233 · 2000 [cited by applicant]
KR 20160131453 · 2016 [cited by applicant]
RU 2342074 · 2008 [cited by applicant]
RU 2011146409 · 2013 [cited by applicant]
UA 58034 · 2011 [cited by applicant]
WO WO2012068545 · 2012 [cited by applicant]
WO WO2017214203 · 2017 [cited by applicant]
WO WO2018060996 · 2018 [cited by applicant]
WO WO2018076284 · 2018 [cited by applicant]
WO WO2018112198 · 2018 [cited by applicant]
Vadalà, Maria, et al. “Retinal and choroidal vasculature changes associated with chronic kidney disease.” Graefe's Archive for Clinical and Experimental Ophthalmology 257 (2019): 1687-1698. DOI:10.1007/s00417-019-04358-… [cited by examiner]
Devamalar et al., “An Architecture for a Fully Automated Real-Time Web-Centric Expert System,” World Academy of Science, Engineering and Technology, 2007, 35:34-38. [cited by applicant]
Goh et al., “Retinal Imaging Techniques for Diabetic Retinopathy Screening,” J Diabetes Sci Technol, Mar. 2016, 10(2): 282-294. [cited by applicant]
nybpinc.com [online], “Corporate Wellness,” retrieved on Dec. 14, 2018, retrieved at URL <https://www.nybpinc.com/corporate-wellness-program>, 10 pages. [cited by applicant]
PCT International Search Report and Written Opinion in International Appln. No. PCT/US2020/043702, mailed Nov. 3, 2020, 13 pages. [cited by applicant]
The Australian Kidney Foundation, “Annual Report 2012,” Kidney Health Australia, Dec. 2011, 65 pages. [cited by applicant]
wellbeingpeople.com [online], “The Wellbeing Directory, ” 2017, retrieved at URL <https://www.wellbeingpeople.com/app/uploads/2018/02/Wellbeing-Directory-2017-Email.pdf>, 44 pages. [cited by applicant]
Yip et al., “Retinal Vascular Imaging Markers and Incident Chronic Kidney Disease: A Prospective Cohort Study,” Scientific Reports, Aug. 2017, 7(9374):1-9. [cited by applicant]